Establishment of a Multi‐Stage In Vitro Screening Platform to Identify Candidate Compounds for Intestinal Mucosal Damage in Inflammatory Bowel Disease
Year: 2026
Type: article
Abstract: Mucosal healing is a key therapeutic goal in inflammatory bowel disease (IBD), which is characterized by mucosal lesions in the gastrointestinal tract. For IBD drug development, it is important to identify multiple compounds with strong effects on mucosal injury and different mechanisms of action. Here, we established an intestinal organoid-based assay to evaluate cytokine-induced inflammatory and epithelial stress responses. We also developed an intestinal microphysiological system (intestinal MPS)-based assay for quantitative evaluation of cytokine-induced changes in mucosal architecture. By integrating these assays, we constructed a multi-stage screening platform to identify candidate compounds that suppress inflammatory responses and preserve mucosal architecture. Tofacitinib, an approved IBD drug, showed positive effects in these assays, supporting the relevance of this platform. Although organoid-based screening identified pimitespib as a candidate compound, pimitespib did not improve mucosal architecture in the intestinal MPS. Consistently, pimitespib failed to restore mucosal morphology in an IBD mouse model. These findings suggest that combining intestinal organoids with an intestinal MPS may help identify candidate compounds that suppress inflammatory responses while preserving mucosal architecture.
Source: Advanced Healthcare Materials
DOI: 10.1002/adhm.71984
Institutions: Kyoto University, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo, Center for iPS Cell Research and Application, Kyoto University, Nozaki Tokushukai Hospital, Institute for the Advanced Study of Human Biology, Kyoto University, The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center, The University of Tokyo
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,880
Awards: 炎症性腸疾患研究のための腸管神経叢を有する腸管モデルの開発, G3080156411, G3321187909, Development and Application of an Intestinal Microphysiological Systems with Sensor Functions, G4256824267, 腸管粘膜チップを用いた炎症性腸疾患の再現と病態解明, Development and application of a human small intestine tissue-on-a-chip for advancing next-generation medicine, オルガノイドと臓器チップを用いた炎症性腸疾患モデルの構築および創薬応用, G6121549825, 腎毒性・薬物動態試験への応用を目指した高次 in vitro 近位尿細管モデルの開発, G63749486, G649412278, G6659902712, G711223365, G7135259336
OpenAlex ID: W7233870529
